Blood Cancer

As the 10th most common cancer in the United States, leukemia will affect up to 2 percent of Americans at some point in their lifetime.

Pepaxto was deemed to have 'potential detriment in overall survival' in patients in a phase 3 trial, prompting ...

A research team from the Faculty of Medicine at the University of Hong Kong (HKUMed) has identified a ...

Clinical trial findings showed both treatments could reduce pain from vaso-occlusive events, hallmarks of sickle cell disease.

ANAHEIM, Calif.—Thousands gathered at Angel Stadium on Nov. 17 to support fundraising efforts to end blood cancer through ...

Children with acute myeloid leukemia (AML) who develop drug resistance generally lack treatment options and are deemed incurable. ...

Pfizer has announced plans to acquire Canadian drug developer Trillium Therapeutics Inc. in a $2.26 billion deal meant ...

“It’s not about winning, it’s about what can be done through the collective efforts of a team,” Jennifer ...